Menopause Hormone Replacement Therapy and Breast Cancer

The hormone replacement therapy for menopause given systematically lived. Place a customized prescription and depending on the existence or not of symptoms.
Disputed benefits, risks demonstrated in 2002, the publication of a U.S. study called WHI (for Women’s Health Initiative) was the effect of a thunderclap in the sky treatment of menopause. Since the results of European and French have prompted health authorities in reducing the signs of hormonal treatment of menopause. But concretely, what does attitude to adopt towards treatment when menopause in women was happened?

Treatment measure

Menopause HRT treatment “Today, treatments are reserved primarily for women suffering from climacteric, i.e. hot flashes, joint pain, vaginal dryness, etc., They take “some time”, time disturbances, generally 4 to 5 years. The ideal combination of an estrogen hormone is administered dermally (patch or gel) which adds natural progesterone (Utrogestan or one of its generic tablets). Another proposal of experts, tibolone (Livial), a hormone replacement therapy for menopause alone to estrogen and progestin effects at the same time, effective bursts of heat and the bone without the disadvantages of hormone replacement therapy (THS) “classic” on the breast.

What are the real hormone replacement therapy risks?

This strategy reasonable THS counseling based on the results of a number of studies. Thus, hormones are a proxy for risk of phlebitis or pulmonary embolism who we know due to take estrogen pills. Then heart disease, which related to the type of progestin: “The molecule chosen by the Americans is very little used in France.

Finally, the third risk is breast cancer, confirmed by all studies. But it appears that HRT reveals cancer rather than creates it, and ultimately, the mortality rate is the same as you take HRT or not. Perhaps it would be even better prognosis when they receive HRT because their breast cancers are different and they are better to be monitored. What we do know is that women, who do not have received a progestin, because their uterus had been removed in the past, did not breast cancer. Two hormones of natural progesterone and tibolone, have proved so far without any inconvenience to the breast. The second is also tested for 3 years in the “worst” conditions, in women who have had breast cancer.

Finally, if we all work reanalysis recent treatment of menopause would have positive effects when it is given soon after menopause and not after 60 years, as was the case in the WHI study where HRT was administered to prevent the consequences of aging.